Abstract
Background: Dysembryoplastic Neuroepithelial Tumours (DNT) are benign brain lesions arising during childhoodthat are characterized by early onset partial seizures, no neurological deficit and cortical location. Pathological diagnosisis easy when the glioneuronal element is present. Its absence might lead to the diagnosis of non-specific DNT orlow-grade glioma (LGG).
Objective: The aim of this retrospective study was to analyse clinicopathological and molecular features of a series of corticaltumours, in order to find diagnostic and prognostic markers to better custom treatment next.Methods: Twenty four children with cortical neuroepithelial tumour were included. Clinical and radiological data werecollected. Histological diagnosis was reviewed for all patients. 1p19q and p53 status were obtained by FISH and immunohistochemistryrespectively. IDH1-2 gene mutations were assessed by DNA sequencing. CGH-array was performed in6/24 samples.Results: We recorded 13 DNT and 11 cortical LGG. Median age at surgery was 11.5 years. Overall survival was 100%and event-free survival at 10 years was 70%. No tumour displayed chromosomal alteration or 1p19q deletion or p53 expression.Only one patient with grade-II oligoastrocytoma had an IDH1 mutation. No statistical difference was found betweenthe two populations in terms of age, sex, tumour location, type of surgical resection, disease progression and clinicalstatus at last follow-up. Only the occurrence of septations on preoperative MRI was significantly associated withpathological features of DNT.Conclusion: Patients with DNT and cortical LGG share excellent outcome. Our genetic analysis could not distinguishDNT from LGG. In particular, CGH-array analysis was strictly normal in both tumor types. In attempt to find molecularmarkers, diagnosis of these lesions remains difficult when the glioneuronal element is lacking.Keywords:Biological and genetic markers, Dysembryoplasic Neuroepithelial Tumours (DNT), IDH1 gene, low grade glioma,glioneuronal element
Current Topics in Medicinal Chemistry
Title:Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?
Volume: 12Issue: 15
Author(s):Laetitia Padovani, Carole Colin, Carla Fernandez, Andre Maues de Paula, Sandy Mercurio, Didier Scavarda, Frederic Frassineti, Jose Adelaide, Anderson Loundou, Dominique Intagliata, Corinne Bouvier, Gabriel Lena, Daniel Birnbaum, Nadine Girard and Dominique Figarella-Branger
Affiliation:
Keywords:Biological and genetic markers, Dysembryoplasic Neuroepithelial Tumours (DNT), IDH1 gene, low grade glioma,glioneuronal element
Abstract: Background: Dysembryoplastic Neuroepithelial Tumours (DNT) are benign brain lesions arising during childhoodthat are characterized by early onset partial seizures, no neurological deficit and cortical location. Pathological diagnosisis easy when the glioneuronal element is present. Its absence might lead to the diagnosis of non-specific DNT orlow-grade glioma (LGG).
Objective: The aim of this retrospective study was to analyse clinicopathological and molecular features of a series of corticaltumours, in order to find diagnostic and prognostic markers to better custom treatment next.Methods: Twenty four children with cortical neuroepithelial tumour were included. Clinical and radiological data werecollected. Histological diagnosis was reviewed for all patients. 1p19q and p53 status were obtained by FISH and immunohistochemistryrespectively. IDH1-2 gene mutations were assessed by DNA sequencing. CGH-array was performed in6/24 samples.Results: We recorded 13 DNT and 11 cortical LGG. Median age at surgery was 11.5 years. Overall survival was 100%and event-free survival at 10 years was 70%. No tumour displayed chromosomal alteration or 1p19q deletion or p53 expression.Only one patient with grade-II oligoastrocytoma had an IDH1 mutation. No statistical difference was found betweenthe two populations in terms of age, sex, tumour location, type of surgical resection, disease progression and clinicalstatus at last follow-up. Only the occurrence of septations on preoperative MRI was significantly associated withpathological features of DNT.Conclusion: Patients with DNT and cortical LGG share excellent outcome. Our genetic analysis could not distinguishDNT from LGG. In particular, CGH-array analysis was strictly normal in both tumor types. In attempt to find molecularmarkers, diagnosis of these lesions remains difficult when the glioneuronal element is lacking.Export Options
About this article
Cite this article as:
Padovani Laetitia, Colin Carole, Fernandez Carla, Maues de Paula Andre, Mercurio Sandy, Scavarda Didier, Frassineti Frederic, Adelaide Jose, Loundou Anderson, Intagliata Dominique, Bouvier Corinne, Lena Gabriel, Birnbaum Daniel, Girard Nadine and Figarella-Branger Dominique, Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?, Current Topics in Medicinal Chemistry 2012; 12 (15) .https://dx.doi.org/10.2174/156802612803531450
DOI https://dx.doi.org/10.2174/156802612803531450 | Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher | Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
Addressing the Most Common Causes of Death with Niacin/NAD and Inositol Polyphosphates
The most common causes of death in the world are cardiovascular disease (CVD) and cancer. These are perhaps best addressed by reducing lipodystrophy and blockages with niacin and inositol polyphosphates (e.g., IP6+inositol) respectively when addressing CVD. Niacin serves as a vitamin by virtue of its role as a skeletal precursor ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
- Protein Kinase C and Prostate Carcinogenesis: Targeting the Cell Cycle and Apoptotic Mechanisms
Current Drug Targets Application of Transcranial Color-Coded Duplex Sonography in Stroke Diagnosis
Current Medical ImagingGold Nanoparticles - Synthesis and Applications in Cancer Management
Recent Patents on Materials SciencePotential Therapeutic Targets in Energy Metabolism Pathways of Breast Cancer
Current Cancer Drug TargetsSphingosine Kinases Signalling in Carcinogenesis
Mini-Reviews in Medicinal ChemistryComprehensive Analysis of Key Proteins Involved in Radioresistance of Prostate Cancer by Integrating Protein-protein Interaction Networks
Current BioinformaticsLet-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric Cancer
Anti-Cancer Agents in Medicinal ChemistryEpigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication
Current Drug Metabolism Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Combinatorial Chemistry & High Throughput Screening Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer
Recent Patents on Anti-Cancer Drug DiscoveryFeature Selection Using Information Distance Measure for Gene Expression Data
Current Proteomics Therapeutic Perspectives of Inhibitors of Endocannabinoid Degradation
Current Drug Targets - CNS & Neurological Disorders EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Current Cancer Drug TargetsRole of Isoprenoid Compounds on Angiogenic Regulation: Opportunities and Challenges
Current Medicinal ChemistryEditorial (Thematic Issue: Emerging Concepts and Therapeutics Strategies for the Treatment of Brain Tumors)
Anti-Cancer Agents in Medicinal Chemistry Small Molecule Complementarity As A Source of Novel Pharmaceutical Agents and Combination Therapies
Current Pharmaceutical DesignDrug Repositioning for Treatment of Movement Disorders: From Serendipity to Rational Discovery Strategies
Current Topics in Medicinal Chemistry Editorial [Hot Topic:Angiogenesis Agents(Executive Editor: Cezary Marcinkiewicz)]
Current Pharmaceutical DesignRecent Patents on Mesenchymal Stem Cell Mediated Therapy in Inflammatory Diseases
Recent Patents on Inflammation & Allergy Drug DiscoveryHistorical Spice as a Future Drug: Therapeutic Potential of Piperlongumine
Current Pharmaceutical Design
[8]ページ先頭